HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

α5GABAA receptors play a pronociceptive role and avoid the rate-dependent depression of the Hoffmann reflex in diabetic neuropathic pain and reduce primary afferent excitability.

Abstract
Diabetic neuropathy is an incapacitating complication in diabetic patients. The cellular and molecular mechanisms involved in this pathology are poorly understood. Previous studies have suggested that the loss of spinal GABAergic inhibition participate in painful diabetic neuropathy. However, the role of extrasynaptic α5 subunit-containing GABAA (α5GABAA) receptors in this process is not known. The purpose of this study was to investigate the role of α5GABAA receptors in diabetes-induced tactile allodynia, loss of rate-dependent depression (RDD) of the Hoffmann reflex (HR), and modulation of primary afferent excitability. Intraperitoneal administration of streptozotocin induced tactile allodynia. Intrathecal injection of α5GABAA receptor inverse agonist, L-655,708, produced tactile allodynia in naive rats, whereas it reduced allodynia in diabetic rats. In healthy rats, electrical stimulation of the tibial nerve at 5 Hz induced RDD of the HR, although intrathecal treatment with L-655,708 (15 nmol) abolished RDD of the HR. Streptozotocin induced the loss of RDD of the HR, while intrathecal L-655,708 (15 nmol) restored RDD of the HR. L-655,708 (15 nmol) increased tonic excitability of the primary afferents without affecting the phasic excitability produced by the primary afferent depolarization. α5GABAA receptors were immunolocalized in superficial laminae of the dorsal horn and L4 to L6 dorsal root ganglion. Streptozotocin increased mean fluorescence intensity and percentage of neurons expressing α5GABAA receptors in dorsal horn and L4 to L6 dorsal root ganglia in 10-week diabetic rats. Our results suggest that spinal α5GABAA receptors modulate the HR, play an antinociceptive and pronociceptive role in healthy and diabetic rats, respectively, and are tonically active in primary afferents.
AuthorsJosé E Hernández-Reyes, Ana B Salinas-Abarca, Guadalupe C Vidal-Cantú, Guadalupe Raya-Tafolla, David Elias-Viñas, Vinicio Granados-Soto, Rodolfo Delgado-Lezama
JournalPain (Pain) Vol. 160 Issue 6 Pg. 1448-1458 (06 2019) ISSN: 1872-6623 [Electronic] United States
PMID31107414 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Carrier Proteins
  • GABA-A Receptor Agonists
  • Receptors, GABA-A
Topics
  • Animals
  • Axons (drug effects, pathology)
  • Carrier Proteins (metabolism)
  • Diabetes Mellitus, Experimental (complications, drug therapy)
  • Diabetic Neuropathies (complications, drug therapy)
  • Female
  • GABA-A Receptor Agonists (pharmacology)
  • Ganglia, Spinal (drug effects, pathology)
  • Hyperalgesia (chemically induced, etiology)
  • Neural Inhibition (drug effects, physiology)
  • Rats, Wistar
  • Receptors, GABA-A (drug effects)
  • Reflex (drug effects, physiology)
  • Spinal Cord Dorsal Horn (drug effects, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: